dapsone	is a	antibiotic
dapsone	treats	leprosy
dapsone	reduces	bacterial load
dapsone	causes	hemolysis
dapsone	contraindicated in	G6PD deficiency
clofazimine	is a	antibiotic
clofazimine	treats	leprosy
clofazimine	causes	skin discoloration
clofazimine	accumulates in	macrophages
rifampin	is a	antibiotic
rifampin	treats	leprosy
rifampin	induces	cytochrome P450
rifampin	reduces	drug levels
rifampin	contraindicated with	warfarin
ethambutol	is a	antibiotic
ethambutol	treats	leprosy
ethambutol	causes	optic neuropathy
ethambutol	requires	baseline eye exam
dapsone	used in	multidrug therapy
clofazimine	used in	multidrug therapy
rifampin	used in	multidrug therapy
ethambutol	used in	multidrug therapy
multidrug therapy	reduces	relapse risk
multidrug therapy	duration	12 months
multidrug therapy	improves	treatment success
dapsone	metabolized by	N-acetyltransferase
N-acetyltransferase	polymorphism	affects toxicity
clofazimine	metabolized by	hepatic enzymes
rifampin	metabolized by	CYP3A4
ethambutol	excreted by	kidneys
renal impairment	requires	dose adjustment
dapsone	interacts with	sulfonamides
clofazimine	interacts with	antiretroviral drugs
rifampin	interacts with	antiretroviral drugs
ethambutol	interacts with	antiretroviral drugs
dapsone	causes	methemoglobinemia
methemoglobinemia	treated with	methylene blue
dapsone	causes	skin rash
skin rash	indicates	hypersensitivity
hypersensitivity	requires	drug discontinuation
dapsone	causes	leukopenia
leukopenia	indicates	bone marrow suppression
clofazimine	causes	peripheral neuropathy
peripheral neuropathy	monitored by	nerve conduction studies
rifampin	causes	hepatotoxicity
hepatotoxicity	monitored by	liver enzymes
ethambutol	causes	visual acuity loss
visual acuity loss	monitored by	visual field test
dapsone	used in	leprosy reaction management
clofazimine	used in	leprosy reaction management
rifampin	used in	leprosy reaction management
ethambutol	used in	leprosy reaction management
leprosy reaction	type 1	is a	immune reaction
leprosy reaction	type 2	is a	immune complex reaction
type 1 reaction	treated with	corticosteroids
type 2 reaction	treated with	thalidomide
thalidomide	contraindicated in	pregnancy
corticosteroids	cause	immunosuppression
immunosuppression	increases	infection risk
dapsone	reduces	erythema nodosum leprosum
clofazimine	reduces	erythema nodosum leprosum
rifampin	reduces	erythema nodosum leprosum
ethambutol	reduces	erythema nodosum leprosum
dapsone	reduces	nerve damage
clofazimine	reduces	nerve damage
rifampin	reduces	nerve damage
ethambutol	reduces	nerve damage
dapsone	contraindicated in	pregnancy
clofazimine	contraindicated in	pregnancy
rifampin	contraindicated in	pregnancy
ethambutol	contraindicated in	pregnancy
dapsone	contraindicated in	lactation
clofazimine	contraindicated in	lactation
rifampin	contraindicated in	lactation
ethambutol	contraindicated in	lactation
dapsone	contraindicated in	severe liver disease
clofazimine	contraindicated in	severe liver disease
rifampin	contraindicated in	severe liver disease
ethambutol	contraindicated in	severe liver disease
dapsone	contraindicated in	severe kidney disease
clofazimine	contraindicated in	severe kidney disease
rifampin	contraindicated in	severe kidney disease
ethambutol	contraindicated in	severe kidney disease
dapsone	contraindicated in	severe anemia
clofazimine	contraindicated in	severe anemia
rifampin	contraindicated in	severe anemia
ethambutol	contraindicated in	severe anemia
dapsone	contraindicated in	severe hypertension
clofazimine	contraindicated in	severe hypertension
rifampin	contraindicated in	severe hypertension
ethambutol	contraindicated in	severe hypertension
dapsone	contraindicated in	severe diabetes
clofazimine	contraindicated in	severe diabetes
rifampin	contraindicated in	severe diabetes
ethambutol	contraindicated in	severe diabetes
dapsone	contraindicated in	severe osteoporosis
clofazimine	contraindicated in	severe osteoporosis
rifampin	contraindicated in	severe osteoporosis
ethambutol	contraindicated in	severe osteoporosis
dapsone	contraindicated in	severe cardiovascular disease
